Asthma Spacers Market Scope
Asthma is The Most Prevalent Chronic Disease Among Children Worldwide. According to the World Health Organization’s Report, Around 235 Million People Globally are Living With Asthma. Asthma spacers, also known as volume spacers, are the medical devices that are used to increase the ease of administering aerosolized medication from a metered-dose inhaler (MDIs). These devices are used by persons who are not able to breathe deeply while using an inhaler. The asthma spacers help a person in coordinating various actions while using an inhaler. There are several types of spacers available for people with their specific needs.
The Asthma Spacers market study is segmented by Type (Aerochamber, Optichamber, Volumatic, Inspirease and Others), by Application (Hospitals, Clinics, Home Care and Others) and major geographies with country level break-up.
The Asthma Spacers market is moderately fragmented with the presence of many players worldwide. Some of the leading players are adopting some organic and inorganic strategies such as a merger, acquisition, expansion, new product launches, among others in order to gain leading share within the market. Research Analyst at AMA estimates that Global Players will contribute to the maximum growth of Global Asthma Spacers market throughout the predicted period.
Trudell Medical International (Canada), PARI GmbH (Germany), GlaxoSmithKline (United Kingdom), CONMED Corporation (United States), Medical Developments International (Australia), Philips (Netherlands), Merck & Co.Inc (United States), Cipla Limited (India) and AstraZeneca Plc (United Kingdom) are some of the key players that are part of study coverage.
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AdvanceMarketAnalytics has segmented the market of Global Asthma Spacers market by Type, Application and Region.
On the basis of geography, the market of Asthma Spacers has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
In November 2019, Novartis announced that it has entered into an agreement and plan of merger with The Medicines Company to acquire the US-based biopharmaceutical company., and In January 2018, GlaxoSmithKline successfully completed its acquisition of Tesaro, an oncology-focused company through its wholly-owned subsidiary Adriatic acquisition corporation.
In April 2019, Cipla Limited announces that it has launched Niveoli™, India’s first extra-fine particle beclomethasone-formoterol combination hydrofluoroalkane (HFA) inhaler for adults, targeting drug delivery to the small airways. Niveoli™ is a proprietary Cipla inhaler and the latest offering from Cipla in respiratory inhalation therapy that addresses an unmet need associated with obstructive airway diseases (OAD) such as asthma and chronic obstructive pulmonary disorder (COPD).
- Rising Demand for Home Care Respiratory Devices
- Increasing Prevalence of Respiratory Diseases
- Strict Government Regulations Regarding the Use of Respiratory Protection Equipment Mask
- Increasing Number of Awareness Program regarding Respiratory Diseases
- Rising Awareness and Improvement in the Healthcare Infrastructure in Emerging Economies
- High Cost of Devices
- Availability of Alternative Treatments for Asthma
- Lack of Knowledge about Usage
Key Target AudienceIndustry Investors, Asthma Spacers Manufacturers, End-User Industries, Hospitals, Clinics, and Laboratories, Traders, Distributors, and Suppliers, Government and Research Organizations, Associations and Industry Bodies and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase